Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 245 member B (FAM245B) is a predicted protein-coding gene present in humans (HGNC:23475, NCBI Gene:196792)[5]. Its sequence is annotated in gene and protein databases (Ensembl: ENSG00000213185; UniProtKB: Q8N5W8)[5]. The protein has not been characterized as part of any known molecular family such as receptor, enzyme, transporter, or transcription factor, and its biological function, disease relevance, and interaction profile remain unknown. No drugs or approved therapeutics have been described to act on FAM245B, and it is not a clinical biomarker. This protein is best classified as "Other" due to the absence of specific family or functional information. If you require structured data for drug discovery, FAM245B is not a suitable target due to insufficient characterization, lack of functional data, and no association with therapy or disease. This makes the entry valuable for mapping but not actionable for therapeutic targeting.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 245 member B (FAM245B).